Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Lymphoma, Non-Hodgkin × palbociclib × 30 days × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1 Lymphoid 1

Conditions

Breast Neoplasms 11 Ovarian Neoplasms 4 Neoplasm Metastasis 3 Neoplasms 2 Lymphoma 2 Endometrial Neoplasms 2 Uterine Cervical Neoplasms 1 Unilateral Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Recurrence 1 Prostatic Neoplasms 1 Pancreatic Neoplasms 1 Neoplasms by Site 1 Multiple Myeloma 1 Malignant Female Reproductive System Neoplasm 1 Lymphoma, Non-Hodgkin 1 Liposarcoma, Myxoid 1 Liposarcoma 1 Leukemia, Myeloid, Acute 1 Kidney Neoplasms 1 Hereditary Sensory and Autonomic Neuropathies 1 Hematologic Neoplasms 1 Head and Neck Neoplasms 1 Fallopian Tube Neoplasms 1 Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer 1 ER+ HER2- Advanced Breast Cancer 1 Colonic Neoplasms 1 Carcinoma, Renal Cell 1 Breast Diseases 1 Brain Neoplasms 1

Interventions

Cyclophosphamide 14 Rituximab 12 fludarabine 11 obinutuzumab 8 fludarabine phosphate 6 tocilizumab 5 ibrutinib 5 Prednisone 5 Lenalidomide 5 glofitamab 4 Specimen Handling 4 Doxorubicin 4 Biopsy 4 polatuzumab vedotin 3 pirtobrutinib 3 X-Rays 3 Vincristine 3 Phantoms, Imaging 3 Mycophenolic Acid 3 Magnetic Resonance Spectroscopy 3 venetoclax 2 acalabrutinib 2 Whole-Body Irradiation 2 Thiotepa 2 Tacrolimus 2 Oxaliplatin 2 Nuclear Medicine Department, Hospital 2 Leukapheresis 2 Granulocyte Colony-Stimulating Factor 2 Gemcitabine 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03297606 2026-03-04

CAPTUR

Canadian Cancer Trials Group

Phase 2 Recruiting

LymphoidPlasma cell

Lymphoma, Non-Hodgkin, Multiple Myeloma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡